Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism.

Aya SaikiMichio OtsukiKosuke MukaiReiko HayashiIichiro ShimomuraIsao KuriharaTakamasa IchijoYoshiyu TakedaTakuyuki KatabamiMika TsuikiNorio WadaYoshihiro OgawaJunji KawashimaMasakatsu SoneNobuya InagakiTakanobu YoshimotoRyuji OkamotoKatsutoshi TakahashiHiroki KobayashiKouichi TamuraKohei KamemuraKoichi YamamotoShoichiro IzawaMiki KakutaniMasanobu YamadaAkiyo TanabeMitsuhide Naruse

Published in: Journal of the Endocrine Society (2020)

Plasma aldosterone concentration at baseline was a significant and independent predictor of absent clinical success of ADX and MRA. Mineralocorticoid receptor antagonist treatment appeared to be a better therapeutic choice than ADX in the nPA group.

Keyphrases

angiotensin ii
magnetic resonance imaging
magnetic resonance
combination therapy
computed tomography
contrast enhanced
decision making
metabolic syndrome
insulin resistance
replacement therapy
smoking cessation